Status:
ACTIVE_NOT_RECRUITING
Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome
Lead Sponsor:
Sohag University
Conditions:
Steroid-Dependent Nephrotic Syndrome; Hypercalciuria
Steroid Dependent Nephrotic Syndrome
Eligibility:
All Genders
2-16 years
Brief Summary
Prevelance of hypercalciurea in children with sterorid dependent nephrotic syndrome
Detailed Description
Prevelance of hypercalciurea in steroid dependent nephrotic syndrome
Eligibility Criteria
Inclusion
- \- Age between 2 and 16 years.
- Diagnosis of steroid-dependent nephrotic syndrome (according to standard clinical criteria).
- Currently in remission or relapse while on steroid therapy.
Exclusion
- \- Children with congenital or secondary nephrotic syndrome.
- Presence of other chronic kidney diseases.
- Use of medications that affect calcium metabolism (other than steroids).
- Children with systemic diseases affecting bone or mineral metabolism.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07194213
Start Date
January 1 2024
End Date
April 1 2026
Last Update
September 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hospital
Sohag, Egypt, 82524
2
Sohag university hospital
Sohag, Egypt